Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine extended-release tablet is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine extended-release tablet may also be used where the clinical presentation suggests a possible vasospastic component but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion or in unstable angina where electrocardiographic findings are compatible with intermittent vasospasm, or when angina is refractory to nitrates and/or adequate doses of beta-blockers. nifedipine extended-release tablet is indicated for the management of chronic stab

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

stat rx usa llc - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 10 mg - i. vasospastic angina : nifedipine is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine may also be used where the clinical presentation suggests a possible vasospastic component but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion or when angina is refractory to nitrates and/or adequate doses of beta blockers. ll. chronic stable angina (classical effort-associated angina) : nifedipine is indicated for the management of chronic stable angina (effort-associated angina) without evidence of vasospasm i

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

leading pharma, llc - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine capsules, usp (nifedipine) is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine capsules, usp may also be used where the clinical presentation suggests a possible vasospastic component but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion or when angina is refractory to nitrates and/or adequate doses of beta-blockers. nifedipine capsules, usp is indicated for the management of chronic stable angina (effort-associated angina) without evidence of vasospasm in patients who remain symptomatic despite adequate

Canada - Tiếng Anh - Health Canada

mylan pharmaceuticals ulc - nifedipine - tablet (extended-release) - 60mg - nifedipine 60mg - dihydropyridines

Canada - Tiếng Anh - Health Canada

mylan pharmaceuticals ulc - nifedipine - tablet (extended-release) - 30mg - nifedipine 30mg - dihydropyridines

Canada - Tiếng Anh - Health Canada

mylan pharmaceuticals ulc - nifedipine - tablet (extended-release) - 20mg - nifedipine 20mg - dihydropyridines

Canada - Tiếng Anh - Health Canada

pharmascience inc - nifedipine - tablet (extended-release) - 60mg - nifedipine 60mg - dihydropyridines

Canada - Tiếng Anh - Health Canada

pharmascience inc - nifedipine - tablet (extended-release) - 30mg - nifedipine 30mg - dihydropyridines

Canada - Tiếng Anh - Health Canada

pharmascience inc - nifedipine - tablet (extended-release) - 20mg - nifedipine 20mg - dihydropyridines

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

american health packaging - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions, drug interactions. ) nifedipine must not be used in cases of cardiogenic shock. nifedipine is contraindicated in patients with a known hypersensitivity to any component of the tablet.